Canon Medical Launches Hybrid Radiography/Fluoroscopy System
Enabling radiographic and low-dose fluoroscopy exams in the same room, the Adora DRFi system emphasizes a variety of advances for flexibility with patient positioning.
Offering the versatility of performing radiography exams along with the capability of facilitating low-dose fluoroscopy exams with the same device, Canon Medical Systems has launched the Adora DRFi system.
In order to reduce physician strain on staff and promote patient comfort, the Adora DRFi system provides an array of features to foster flexibility with patient positioning.
Offering the dual capability of radiography exams and low-dose fluoroscopy exams with the same device, the newly launched Adora DRFi system garnered FDA clearance in December 2024. (Image courtesy of Canon Medical Systems.)
Allowing exposures from a variety of angles, the Adora DRFi system — which was cleared by the Food and Drug Administration (FDA) in December 2024 — offers independent movement with the device’s X-ray tube and detector arms as well as rotating ceiling unit, according to Canon Medical. The company said other aspects of the system include inMotion auto-positioning technology and a durable carbon fiber table that enables high load capacity and up to 340 degrees of rotation.
Additionally, Canon Medical says the system’s CDXI-RF Wireless B1 Detector allows for docking or wireless use in the exam room for fluoroscopy or radiography exams.
“This system combines versatility, efficiency, and advanced imaging technology in a way that redefines what’s possible in a hybrid radiography and fluoroscopy system,” noted Satrajit Misra, chief sales and marketing officer at Canon Medical Systems.
Where Things Stand with the Radiologist Shortage
June 18th 2025A new report conveys the cumulative impact of ongoing challenges with radiologist residency positions, reimbursement, post-COVID-19 attrition rates and the aging of the population upon the persistent shortage of radiologists in the United States.
How to Successfully Launch a CCTA Program at Your Hospital or Practice
June 11th 2025Emphasizing increasing recognition of the capability of coronary computed tomography angiography (CCTA) for the evaluation of acute and stable chest pain, this author defuses common misperceptions and reviews key considerations for implementation of a CCTA program.
Mammography AI Platform for Five-Year Breast Cancer Risk Prediction Gets FDA De Novo Authorization
June 2nd 2025Through AI recognition of subtle patterns in breast tissue on screening mammograms, the Clairity Breast software reportedly provides validated risk scoring for predicting one’s five-year risk of breast cancer.
